JCR Pharmaceuticals Co., Ltd. (JCRRF) Investment Research Dashboard
About JCR Pharmaceuticals Co., Ltd. (JCRRF) stock analysis
Get live JCRRF stock price $3.31, comprehensive JCR Pharmaceuticals Co., Ltd. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time JCRRF stock data and investment insights.
Loading chart data...
JCR Pharmaceuticals Co., Ltd. (JCRRF) Overview
JCR Pharmaceuticals Co., Ltd. (JCRRF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, JCRRF trades at $3.31 with a market capitalization of 403.80M . Over the past 52 weeks, JCRRF has traded between $3.15 and $5.00 , with the current price positioned at approximately 9% of this range . The ...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 403.80M
- Current price: $3.31
- 52-week range: $3.15 - $5.00
- P/E ratio: 28.00
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
JCR Pharmaceuticals Co., Ltd., a specialized pharmaceutical company headquartered in Ashiya, Japan, and established in 1975, operates across the entire lifecycle of pharmaceutical products, regenerative medicines, and active drug substances. Its comp...
Company Information
- CEO
- Toru Ashida
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 985
Contact Information
- Website
- https://www.jcrpharm.co.jp
- Address
- 3-19 Kasuga-cho
- Country
- JP
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 28.0)
✓ Lower volatility stock (Beta: 0.16) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for JCR Pharmaceuticals Co., Ltd. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for JCR Pharmaceuticals Co., Ltd.
- ⚠Investors should consider how JCR Pharmaceuticals Co., Ltd. fits within their overall portfolio allocation
Market Cap
403.80M
P/E Ratio (TTM)
28.00
Beta
0.16
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare JCRRF with peer companies:
- Price
- $0.15+0.00% (1D)
- Market cap
- 756.30M
- Price
- $21.28-5.37% (1D)
- Market cap
- 626.73M
- Price
- $0.64-1.26% (1D)
- Market cap
- 535.91M
- Price
- $31.50+0.00% (1D)
- Market cap
- 546.91M
- Price
- $10.79+0.00% (1D)
- Market cap
- 851.77M
- Price
- $0.09+0.00% (1D)
- Market cap
- 14.67M
- Price
- $0.00+0.00% (1D)
- Market cap
- 16.55K
- Price
- $0.00+0.00% (1D)
- Market cap
- 1.71K
- Price
- $6.10+8.31% (1D)
- Market cap
- 559.56M
- Price
- $1.30+0.00% (1D)
- Market cap
- 470.36M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.7 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.5% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 37/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.